Last reviewed · How we verify

NCT05966545: IOFB

Extraction Routes of Intraocular Foreign Body

Status unknown NA Last updated 28 July 2023
What this trial tests

NA trial testing pars plana vitrectomy and intraocular foreign body removal in Intraocular Foreign Body in 48 participants. Status unknown.

Timeline
1 January 2022
Primary endpoint
30 August 2023
30 September 2023

Quick facts

Lead sponsorZagazig University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment48
Start date1 January 2022
Primary completion30 August 2023
Estimated completion30 September 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Zagazig University

Who can join

Eligibility, any sex, with Intraocular Foreign Body. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Intra ocular foreign body removal is indicated to avoid further many complications such as retinal detachment, endophthalmitis. The surgical approach for a posterior segment IOFB is pars plana vitrectomy and its extraction either through the pars plana. our study is to compare limbal route versus pars plana route for extraction of posterior segment IOFB associated with cataract as regard to safety and complications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Zagazig University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05966545.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing